[{"bbox": [89, 96, 372, 133], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [89, 168, 1561, 237], "category": "Text", "text": "422 Million, propelled by continued advancements in technology, increasing investments, and a rising demand for precision diagnostics."}, {"bbox": [89, 263, 1564, 494], "category": "Text", "text": "**East and Northeast India:** In 2024, the IVD market in East and Northeast India is valued at USD 148 Million. This region, encompassing states like West Bengal, Odisha, Bihar, Jharkhand, Assam, and the northeastern states, has traditionally grappled with limited healthcare infrastructure and insufficient diagnostic facilities. However, ongoing healthcare reforms and advancements in laboratory networks are progressively advancing the market. There is also a noticeable surge in demand for molecular diagnostics, immunoassays, and automated diagnostic solutions for diseases like cancer, tuberculosis, and vector-borne diseases like malaria and dengue. By 2025, the market in this region is expected to grow to USD 172 Million, driven by the increasing adoption of digital diagnostics, molecular testing technologies, and the rise in local production of IVD kits under the Make in India initiative."}, {"bbox": [98, 529, 650, 567], "category": "Caption", "text": "Chart 21: Market Share by Region â€“ CY 2024"}, {"bbox": [98, 562, 1075, 1030], "category": "Picture"}, {"bbox": [98, 1030, 603, 1067], "category": "Text", "text": "Source: Imarc Research, CareEdge Research"}, {"bbox": [89, 1074, 1564, 1269], "category": "Text", "text": "In 2024, the IVD market in India is led by North India, holding a 36.8% share, driven by the region's large metropolitan presence, high disease burden, and supportive government initiatives like Ayushman Bharat. South India follows with a 29.5% share, fuelled by the prevalence of lifestyle diseases, strong healthcare programs, and being a manufacturing hub for medical devices. West and Central India contribute 23.9% to the market, benefiting from urban growth, advanced diagnostic adoption, and biotech clusters in cities like Pune and Ahmedabad. East India, with a smaller share of 9.8%, faces challenges in healthcare infrastructure but is witnessing growth due to ongoing reforms, rising infectious diseases, and emerging diagnostic hubs like Kolkata."}, {"bbox": [91, 1299, 680, 1333], "category": "Section-header", "text": "## Key Growth Drivers of the Indian Vitro Industry"}, {"bbox": [89, 1361, 1561, 1431], "category": "Text", "text": "The in vitro diagnostics (IVD) market has been experiencing significant growth, driven by several factors. Below are key growth demands in the IVD market based on the following points:"}, {"bbox": [89, 1456, 1564, 1718], "category": "List-item", "text": "1. **Growing Geriatric Population:** As the Indian geriatric population (typically aged 65 and above) continues to grow, there is an increased prevalence of age-related health issues such as diabetes, cancer, and neurological disorders. This shift drives a higher demand for IVD tests, which play a crucial role in monitoring, diagnosing, and managing these conditions. Older adults are more susceptible to chronic diseases, necessitating regular diagnostic testing for conditions like blood glucose levels, kidney function, and cholesterol management. This growing need for ongoing monitoring ensures a steady demand for IVD solutions that aid disease management. Furthermore, as the elderly population increases, personalized healthcare becomes more important. IVD tests enable physicians to tailor treatment plans to individual patients based on specific diagnostic results, ensuring more effective and customized care for aging individuals."}, {"bbox": [89, 1745, 1564, 2102], "category": "List-item", "text": "2. **Technological Advancements:** Technological advancements in the IVD market have significantly transformed the landscape of medical testing. Innovations in automation, miniaturization (the process of significantly reducing the size of medical diagnostic devices used to analyse bodily samples (like blood or urine) outside the body), and artificial intelligence have improved the accuracy, speed, and accessibility of diagnostic tools, encouraging more healthcare facilities to adopt these advanced technologies. Additionally, breakthroughs in molecular diagnostics (a laboratory method that identifies diseases or disease risk by analysing molecules like DNA, RNA, and proteins present in a tissue or fluid sample), such as PCR (Polymerase Chain Reaction) and next-generation sequencing (NGS), have allowed for more precise and efficient detection of infections, genetic disorders, and cancers, further driving market growth. Furthermore, advancements in point-of-care (POC) technologies enable testing outside traditional laboratories, providing faster results and improving disease management, especially in remote or underserved regions where access to central healthcare facilities may be limited. These technological innovations are reshaping the way diagnostic testing is performed, fuelling the expansion of the IVD market."}]